COVID-19

News

Gilead working with generics firms to boost global supply of...

Gilead has outlined plans to work with generics firms to rapidly increase production of its COVID-19 drug remdesivir to meet global demand.

Views & Analysis

4 tips for switching to virtual meetings

Coronavirus has forced pharma companies to take their meetings online – including everything from small team calls to major congresses.

News

Pfizer/BioNTech dose first US patients with COVID-19 vaccine

Pfizer and its development partner BioNTech have begun dosing the first people in the US with a potential COVID-19 vaccine, as part of their ongoing phase 1/2 clinical trial.

News

Hepatitis drug could be tested against COVID-19 in India

India’s Zydus Cadila wants to test a form of interferon, usually used against hepatitis B and C, as a potential treatment for the virus that causes COVID-19.

News

BerGenBio raises 45 million euros for COVID-19 drug developm...

Norway’s BerGenBio has raised 500 million Norwegian kroner – around $45.4 million euros – in an oversubscribed private placement to develop its pipeline that includes a potential COVID-19 t

News

Young sporty woman practicing yoga, doing upward facing dog exercise, Urdhva mukha shvanasana pose, working out, wearing sportswear, pants and top, indoor full length, white yoga studio

Lockdown sparks global yoga craze, digital health survey sho...

Digital health firm Withings has used its technology to produce a read-out of how COVID-19 lockdowns have affected the health of its users, showing a smaller than expected increase in weigh

Gilead working with generics firms to boost global supply of...

4 tips for switching to virtual meetings

Pfizer/BioNTech dose first US patients with COVID-19 vaccine

Hepatitis drug could be tested against COVID-19 in India

BerGenBio raises 45 million euros for COVID-19 drug developm...

Lockdown sparks global yoga craze, digital health survey sho...

With measles cases rising, UK launches vaccination drive

Discover a new era of healthcare panel engagement: Grounded ...

COVID-19

Editor's Picks